The maker of Ozempic and Wegovy is researching groundbreaking new drugs to stop people from becoming obese in the first place
The blockbuster obesity drugs Ozempic and Wegovy have sent sales soaring for Danish pharma company Novo Nordisk, up 25% year-over-year in the first quarter of 2023 alone, and the company...








